Biomarkers for heart attack detection
Pro Research Analysisby 
Searched over 200M research papers
Key Biomarkers for Heart Attack Detection
Cardiac Troponins: The Gold Standard for Myocardial Infarction Diagnosis
Cardiac troponins (cTnI and cTnT) are the most specific and sensitive biomarkers for detecting heart attacks (myocardial infarction). High-sensitivity assays for cardiac troponin allow for early and accurate diagnosis, even within hours of symptom onset, making them the primary tool in clinical practice for heart attack detection 1245+1 MORE.
Enzyme Markers: Early Indicators of Myocardial Injury
Enzyme markers such as creatine kinase-MB (CK-MB), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and heart-type fatty acid-binding protein (H-FABP) are also used to detect myocardial injury. H-FABP, in particular, is valuable for early diagnosis due to its rapid release after heart muscle damage 1245.
Inflammatory and Oxidative Stress Markers
Markers like C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), myeloperoxidase (MPO), interleukin-6 (IL-6), and growth differentiation factor-15 (GDF-15) provide information about inflammation and oxidative stress, which are associated with heart attack risk and prognosis 1235+1 MORE.
Peptide and Hormonal Biomarkers: Assessing Heart Failure and Stress
B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are crucial for diagnosing and managing heart failure, which often follows a heart attack. Other peptide markers like mid-regional pro-adrenomedullin (MR-proADM), copeptin, and endothelin-1 help assess disease severity and stress on the heart 1245+3 MORE.
Markers of Plaque Instability and Lipid Metabolism
Lipoprotein-associated phospholipase A2 (Lp-PLA2), secretory phospholipase A2, and matrix metalloproteinases (MMPs) are linked to plaque instability and atherosclerosis, which can lead to heart attacks. These markers help predict both incident and recurrent cardiovascular events 1235.
Novel and Emerging Biomarkers
Emerging biomarkers such as soluble suppression of tumorigenicity 2 (sST2), galectin-3, pregnancy-associated plasma protein A (PAPP-A), and microRNAs are being studied for their potential to improve early detection, risk stratification, and personalized treatment of heart attacks. These novel markers reflect processes like fibrosis, remodeling, and metabolic dysregulation 1256+1 MORE.
Multi-Marker Approaches and Advanced Detection Methods
Recent advances include multi-marker panels and high-sensitivity detection platforms, such as antibody microarray-based assays, which can simultaneously measure several key biomarkers (e.g., cTnI, H-FABP, CRP, copeptin, myoglobin, D-dimer, NT-proBNP) with high accuracy. These approaches improve diagnostic precision and help differentiate heart attacks from other acute conditions .
Conclusion
Cardiac troponins remain the cornerstone for heart attack detection due to their high specificity and sensitivity. Additional biomarkers—including enzyme markers, inflammatory proteins, peptide hormones, and novel molecules—provide complementary information for early diagnosis, risk assessment, and management. Ongoing research into multi-marker strategies and emerging biomarkers promises to further enhance the accuracy and personalization of heart attack detection and care 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic